Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Revenue

Foghorn Therapeutics had revenue of $33.90M in the twelve months ending March 31, 2024, with 64.41% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.05M, a -4.88% decrease year-over-year. In the year 2023, Foghorn Therapeutics had annual revenue of $34.16M with 77.63% growth.

• Revenue (ttm): $33.90M
• Revenue Growth: +64.41%
• P/S Ratio: 8.88
• Revenue / Employee: $292,207
• Employees: 116
• Market Cap: 300.99M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	34.16M	14.93M	77.63%
Dec 31, 2022	19.23M	17.91M	1,357.77%
Dec 31, 2021	1.32M	889.00K	206.74%
Dec 31, 2020	430.00K	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.